Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
In situ production of ROS in the skin by photodynamic therapy as a powerful tool in clinical dermatology.
Fonda-Pascual P, Moreno-Arrones OM, Alegre-Sanchez A, Saceda-Corralo D, Buendia-Castaño D, Pindado-Ortega C, Fernandez-Gonzalez P, Velazquez-Kennedy K, Calvo-Sánchez MI, Harto-Castaño A, Perez-Garcia B, Bagazgoitia L, Vaño-Galvan S, Espada J, Jaen-Olasolo P. Fonda-Pascual P, et al. Among authors: velazquez kennedy k. Methods. 2016 Oct 15;109:190-202. doi: 10.1016/j.ymeth.2016.07.008. Epub 2016 Jul 12. Methods. 2016. PMID: 27422482 Review.
Hemolytic crisis due to Covid-19 vaccination in a woman with cold agglutinin disease.
Pérez-Lamas L, Moreno-Jiménez G, Tenorio-Núñez MC, Velázquez-Kennedy K, Jiménez-Chillón C, Astibia-Mahillo B, Núñez-Torrón C, García-Gutiérrez V, Jiménez-Martín A, Vallés-Carboneras A, López-Jiménez JF. Pérez-Lamas L, et al. Among authors: velazquez kennedy k. Am J Hematol. 2021 Aug 1;96(8):E288-E291. doi: 10.1002/ajh.26214. Epub 2021 May 15. Am J Hematol. 2021. PMID: 33939851 Free PMC article. No abstract available.
Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study.
Escamilla Gómez V, García-Gutiérrez V, López Corral L, García Cadenas I, Pérez Martínez A, Márquez Malaver FJ, Caballero-Velázquez T, González Sierra PA, Viguria Alegría MC, Parra Salinas IM, Calderón Cabrera C, González Vicent M, Rodríguez Torres N, Parody Porras R, Ferra Coll C, Orti G, Valcárcel Ferreiras D, De la Cámara LLanzá R, Molés P, Velázquez-Kennedy K, João Mende M, Caballero Barrigón D, Pérez E, Martino Bofarull R, Saavedra Gerosa S, Sierra J, Poch M, Zudaire Ripa MT, Díaz Pérez MA, Molina Angulo B, Sánchez Ortega I, Sanz Caballer J, Montoro Gómez J, Espigado Tocino I, Pérez-Simón JA; Grupo Español de Trasplante Hematopoyético (GETH). Escamilla Gómez V, et al. Among authors: velazquez kennedy k. Bone Marrow Transplant. 2020 Mar;55(3):641-648. doi: 10.1038/s41409-019-0731-x. Epub 2019 Nov 7. Bone Marrow Transplant. 2020. PMID: 31700138 Free PMC article.
HCV-positive lymphoma after sustained virological response with direct-acting antiviral agents: The game is not over after HCV eradication.
Rodríguez de Santiago E, Velázquez Kennedy K, García González M, Gea Rodríguez F, Téllez Villajos L, Tavío Hernández E, Albillos A. Rodríguez de Santiago E, et al. Among authors: velazquez kennedy k. J Viral Hepat. 2018 May;25(5):614-615. doi: 10.1111/jvh.12843. Epub 2018 Mar 1. J Viral Hepat. 2018. PMID: 29239080 No abstract available.
Patients with secondary acute myeloid leukemia undergoing allogeneic stem-cell transplant have inferior outcomes than de novo acute myeloid leukemia regardless minimal residual disease level by flow cytometry.
Núñez-Torrón Stock C, Jiménez Chillón C, Martín Moro F, Marquet Palomanes J, Velázquez Kennedy K, Piris Villaespesa M, Roldán Santiago E, Rodríguez Martín E, Chinea Rodríguez A, García Gutiérrez V, Moreno Jiménez G, López Jiménez J, Herrera Puente P. Núñez-Torrón Stock C, et al. Among authors: velazquez kennedy k. Hematol Oncol. 2023 Oct;41(4):753-761. doi: 10.1002/hon.3160. Epub 2023 Apr 20. Hematol Oncol. 2023. PMID: 37081742
Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution.
Garcia-Donas J, Martínez-Urbistondo D, Velázquez Kennedy K, Villares P, Barquin A, Dominguez A, Rodriguez-Moreno JF, Caro E, Suarez Del Villar R, Nistal-Villan E, Yagüe M, Ortiz M, Barba M, Ruiz-Llorente S, Quiralte M, Zanin M, Rodríguez C, Navarro P, Berraondo P, Madurga R. Garcia-Donas J, et al. Among authors: velazquez kennedy k. Front Immunol. 2023 Apr 18;14:1156603. doi: 10.3389/fimmu.2023.1156603. eCollection 2023. Front Immunol. 2023. PMID: 37143685 Free PMC article. Clinical Trial.
Prediction of blood volume to be processed to achieve a target number of CD34+ cells: Development, validation and implementation of a formula.
García-García I, Cid J, Moreno-Jiménez G, Tenorio Núñez M, Jiménez Martín A, Vallés Carboneras A, Velázquez-Kennedy K, Lozano M, López-Jiménez FJ. García-García I, et al. Among authors: velazquez kennedy k. Vox Sang. 2023 Apr;118(4):288-295. doi: 10.1111/vox.13410. Epub 2023 Feb 5. Vox Sang. 2023. PMID: 36740822
National Incidence, Management and Survival of Urachal Carcinoma.
Collins DC, Velázquez-Kennedy K, Deady S, Brady AP, Sweeney P, Power DG. Collins DC, et al. Among authors: velazquez kennedy k. Rare Tumors. 2016 Oct 5;8(3):6257. doi: 10.4081/rt.2016.6257. eCollection 2016 Sep 5. Rare Tumors. 2016. PMID: 27746878 Free PMC article.
11 results